Hemostemix Provides Highlights of 2018 Accomplishments
January 17, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following corporate update on...
Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial
January 03, 2019 08:00 ET
|
Hemostemix Inc.
CALGARY, Alberta, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from two...
Hemostemix Announces OTCQB Listing and DTC Eligibility
October 30, 2018 09:07 ET
|
Hemostemix Inc.
CALGARY, Alberta, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce the Company has been approved for...
Finding a weak link in the frightful parasite Schistosoma
July 10, 2018 08:00 ET
|
Morgridge Institute for Research
Madison, Wis., July 10, 2018 (GLOBE NEWSWIRE) -- The parasitic disease schistosomiasis is one of the developing world’s worst public health scourges, affecting hundreds of millions of people, yet...
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2018
May 22, 2018 07:00 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
Global Market for Stem Cell Techs to Achieve Double-Digit Growth Rate
March 29, 2018 08:00 ET
|
BCC Research
WELLESLEY, Mass., March 29, 2018 (GLOBE NEWSWIRE) -- Stem cell technology has already produced many significant products in terms of therapeutics, creating numerous opportunities within the market....
Predictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell Society Congress
March 05, 2018 09:15 ET
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, March 05, 2018 (GLOBE NEWSWIRE) -- Predictive Biotech, Inc., a wholly owned subsidiary of Predictive Technology Group, Inc. (OTCPINK:PRED) provided a sponsorship at the 4th Annual...
Global Stem Cells Banking Market -- Revolutionary Way to Cure Life-Threatening Diseases through Stem Cell Banking, and is Projected to Reach USD 3761 million, By 2023: Energias Market research Pvt. Ltd.
February 20, 2018 07:06 ET
|
Energias Market Research
NEW YORK, Feb. 20, 2018 (GLOBE NEWSWIRE) -- The global stem cell banking market is expected to grow significantly from USD 1,380 million in 2016 to USD 3,761 million in 2023, at a CAGR of 15.5% from...
Global Cancer Stem Cell Market to Reach Nearly $2B by 2022
January 17, 2018 12:29 ET
|
BCC Research
WELLESLEY, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer stem cells have been found in a range of human tumors and are potential targets for cancer treatment. The global cancer stem cell...
RoosterBio and GenCure expand collaboration to provide end-to-end solutions for hMSC-based therapies
October 02, 2017 09:00 ET
|
BioBridge Global
San Antonio, Texas, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Biotech organizations RoosterBio Inc. and GenCure announced today that they are expanding their existing collaboration by providing end-to-end...